Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus sufentanil as intrathecal adjuvants in spinal anesthesia for elderly hip replacement surgery
ACTRN12623000153617Phase 3Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Mar 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hip osteoarthritis comparing Levobupivacaine + dexmedetomidine with Levobupivacaine + sufentanil (2 arms). Primary endpoints: Onset of sensory block, Duration of sensory block and 1 more. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinesufentanillevobupivacaine
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on ACTRN12623000153617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000153617.